Trium Capital »

Achilles Therapeutics shares owned by Trium Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Trium Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $46k 31k 1.48

More positions owned by Trium Capital

At&t (T)
Sapiens International Corp (SPNS)
Sunopta (STKL)
Hologic (HOLX)
Onestream Cl A Ord Class A (OS)
iShares MSCI Brazil Index (EWZ)
Vaneck Vectors Etf Tr vietnam etf (VNM)
Alumis (ALMS)
Desktop Metal Cl A Ord Class A (DM)
Quanterix Ord (QTRX)
Spdr S&p 500 Etf Put Option (SPY)
First Fndtn (FFWM)
Washington Real Estate Investment Trust (ELME)
Albertsons Companies Cl A Ord Class A (ACI)
Republic Services (RSG)

View all positions for Trium Capital

Top funds holding Achilles Therapeutics

Trium Capital
Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics